HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TMEM126B
transmembrane protein 126B
Chromosome 11 Β· 11q14.1
NCBI Gene: 55863Ensembl: ENSG00000171204.13HGNC: HGNC:30883UniProt: Q8IUX1
41PubMed Papers
21Diseases
0Drugs
16Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
mitochondrial complex I intermediate assembly complexmitochondrial respiratory chain complex I assemblymitochondrionprotein bindingmitochondrial complex I deficiency, nuclear type 29mitochondrial complex I deficiencyneurodegenerative diseasemitochondrial disease
✦AI Summary

TMEM126B is a transmembrane protein that functions as a core component of the mitochondrial complex I intermediate assembly (MCIA) complex, playing an essential role in assembling the membrane arm of mitochondrial respiratory chain complex I 1. As part of the MCIA complex alongside NDUFAF1, ECSIT, and ACAD9, TMEM126B participates in constructing the ND2-module, a critical intermediate during complex I biogenesis, with a hierarchy of stability centered on ACAD9 1. The protein is conserved through evolutionary neofunctionalization after gene duplication 2. TMEM126B deficiency causes severe complex I assembly and content defects, leading to mitochondrial complex I deficiency nuclear type 29 3. Biallelic mutations in TMEM126B cause Leigh-like syndrome with splicing defects, and mutations have been identified in pediatric mitochondrial disease patients and adult kidney failure presentations 3, 4. Under chr11 hypoxia, TMEM126B undergoes HIF-1Ξ±-dependent proteolytic degradation via the E3-ubiquitin ligase Ξ²-TrCP1, reducing complex I abundance and altering mitochondrial respiration 5. TMEM126B knockdown attenuates mtROS production and impairs SDH oxidation-dependent HIF-1Ξ± stabilization in macrophages 6. These findings establish TMEM126B as critical for mitochondrial function and identify it as a genetic target for mitochondrial disease diagnosis.

Sources cited
1
TMEM126B is a core MCIA complex component required for ND2-module assembly and complex I biogenesis
PMID: 32320651
2
Biallelic TMEM126B mutations cause Leigh-like syndrome with severe complex I deficiency through splicing defects
PMID: 36482121
3
TMEM126B variants cause mitochondrial complex I deficiency presenting as kidney failure
PMID: 40970474
4
TMEM126B undergoes HIF-1Ξ±-dependent degradation via Ξ²-TrCP1 under chronic hypoxia
PMID: 29464284
5
TMEM126B deficiency reduces complex I assembly and attenuates mtROS-dependent SDH oxidation
PMID: 30368040
6
TMEM126B evolved through neofunctionalization after gene duplication in complex I assembly
PMID: 27048931
Disease Associationsβ“˜21
mitochondrial complex I deficiency, nuclear type 29Open Targets
0.70Moderate
mitochondrial complex I deficiencyOpen Targets
0.69Moderate
neurodegenerative diseaseOpen Targets
0.51Moderate
mitochondrial diseaseOpen Targets
0.51Moderate
mitochondrial complex I deficiency, nuclear type 1Open Targets
0.37Weak
genetic disorderOpen Targets
0.19Weak
mathematical abilityOpen Targets
0.16Weak
cervical carcinomaOpen Targets
0.15Weak
Abnormal nasolacrimal system morphologyOpen Targets
0.14Weak
device complicationOpen Targets
0.10Suggestive
Benign Thyroid Gland NeoplasmOpen Targets
0.09Suggestive
Alzheimer diseaseOpen Targets
0.09Suggestive
renal dialysisOpen Targets
0.08Suggestive
self-injurious ideationOpen Targets
0.05Suggestive
rhabdomyolysisOpen Targets
0.05Suggestive
dyshidrosisOpen Targets
0.04Suggestive
Abnormality of the skeletal systemOpen Targets
0.03Suggestive
Abnormality of the gastrointestinal tractOpen Targets
0.03Suggestive
medical procedureOpen Targets
0.03Suggestive
complicationOpen Targets
0.02Suggestive
Mitochondrial complex I deficiency, nuclear type 29UniProt
Pathogenic Variants16
NM_018480.7(TMEM126B):c.635G>T (p.Gly212Val)Pathogenic
Mitochondrial disease|Mitochondrial complex I deficiency, nuclear type 29|not provided|Mitochondrial complex I deficiency
β˜…β˜…β˜†β˜†2026β†’ Residue 212
NM_018480.7(TMEM126B):c.241del (p.Thr81fs)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 29
β˜…β˜…β˜†β˜†2025β†’ Residue 81
NM_018480.7(TMEM126B):c.137del (p.Ala46fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 29|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 46
NM_018480.7(TMEM126B):c.397G>A (p.Asp133Asn)Pathogenic
Mitochondrial complex I deficiency, nuclear type 29|not provided|Colon adenocarcinoma
β˜…β˜…β˜†β˜†2025β†’ Residue 133
NM_018480.7(TMEM126B):c.320_321del (p.Tyr107fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 1|not provided|Mitochondrial complex I deficiency, nuclear type 29
β˜…β˜…β˜†β˜†2024β†’ Residue 107
NM_018480.7(TMEM126B):c.290dup (p.Lys98fs)Likely pathogenic
TMEM126B-related disorder|Mitochondrial complex I deficiency, nuclear type 29
β˜…β˜…β˜†β˜†2023β†’ Residue 98
NM_018480.7(TMEM126B):c.421_422del (p.Val141fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 29|not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 141
NM_018480.7(TMEM126B):c.148del (p.Arg50fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 50
NM_018480.7(TMEM126B):c.269del (p.Asn90fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 90
NM_018480.7(TMEM126B):c.187del (p.Tyr63fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 63
NM_018480.7(TMEM126B):c.77_81del (p.Pro26fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 26
NM_018480.7(TMEM126B):c.587T>G (p.Leu196Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 196
NM_018480.7(TMEM126B):c.203+2T>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_018480.7(TMEM126B):c.585dup (p.Leu196fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 196
NM_018480.7(TMEM126B):c.401del (p.Asn134fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 29|Mitochondrial disease
β˜†β˜†β˜†β˜†2018β†’ Residue 134
NM_018480.7(TMEM126B):c.208C>T (p.Gln70Ter)Pathogenic
Mitochondrial complex I deficiency, nuclear type 29
β˜†β˜†β˜†β˜†2018β†’ Residue 70
View on ClinVar β†—
Related Genes
NDUFAF8Shared pathway100%DMAC1Shared pathway100%LYRM2Shared pathway100%NDUFA12Protein interaction100%NDUFB8Protein interaction100%NDUFA6Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Brain
67%
Liver
64%
Lung
56%
Ovary
54%
Bone Marrow
50%
Gene Interaction Network
Click a node to explore
TMEM126BNDUFAF8DMAC1LYRM2NDUFA12NDUFB8NDUFA6
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q8IUX1
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.82LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.30 [0.91–1.82]
RankingsWhere TMEM126B stands among ~20K protein-coding genes
  • #10,101of 20,598
    Most Researched41
  • #2,419of 5,498
    Most Pathogenic Variants16
  • #16,691of 17,882
    Most Constrained (LOEUF)1.82
Genes detectedTMEM126B
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre.
PMID: 27290639
J Transl Med Β· 2016
1.00
2
Proteomic-based stratification of intermediate-risk prostate cancer patients.
PMID: 38052461
Life Sci Alliance Β· 2024
0.90
3
Novel biallelic mutations in TMEM126B cause splicing defects and lead to Leigh-like syndrome with severe complex I deficiency.
PMID: 36482121
J Hum Genet Β· 2023
0.80
4
The origin of the supernumerary subunits and assembly factors of complex I: A treasure trove of pathway evolution.
PMID: 27048931
Biochim Biophys Acta Β· 2016
0.70
5
TMEM126B deficiency reduces mitochondrial SDH oxidation by LPS, attenuating HIF-1Ξ± stabilization and IL-1Ξ² expression.
PMID: 30368040
Redox Biol Β· 2019
0.60